Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PURSUIT: AZD0780 for LDL-C lowering in dyslipidemia on statins
jRCT2031230580Active, not recruiting
- Sponsor
- AstraZeneca
- Start
- Jan 2024
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in dyslipidemia and hypercholesterolemia comparing AZD0780 arm with Placebo arm (2 arms). Primary endpoint: Percent change in LDL-C from baseline to Week 12. Started Jan 2024; status: active, not recruiting.
02
Drugs
laroprovstat
03
Conditions
dyslipidemiahypercholesterolemia
Beyond the preview
Go deeper on jRCT2031230580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230580.